Differential sensitivity of human papillomavirus type 16+ and type 18+ cervical carcinoma cells to CD95-mediated apoptosis
Open Access
- 13 June 2001
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 93 (6) , 823-831
- https://doi.org/10.1002/ijc.1405
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Cultivated H-RS cells are resistant to CD95L-mediated apoptosis despite expression of wild-type CD95Experimental Hematology, 2000
- The E7 protein of human papillomavirus type 16 sensitizes primary human keratinocytes to apoptosisOncogene, 1998
- Human papillomavirus type 16 E7 protein sensitizes cervical keratinocytes to apoptosis and release of interleukin-1αOncogene, 1998
- Mitochondria and ApoptosisScience, 1998
- Bcl-xL Functions Downstream of Caspase-8 to Inhibit Fas- and Tumor Necrosis Factor Receptor 1-induced Apoptosis of MCF7 Breast Carcinoma CellsJournal of Biological Chemistry, 1998
- The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell deathOncogene, 1997
- Association between Cervical Neoplasia and Apoptosis as Detected byin SituNuclear LabelingGynecologic Oncology, 1996
- Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide PerspectiveJNCI Journal of the National Cancer Institute, 1995
- FADD, a novel death domain-containing protein, interacts with the death domain of fas and initiates apoptosisCell, 1995
- Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor familyCell, 1993